Literature DB >> 20615622

Role of radiotherapy in the management of desmoid tumors.

Iris Gluck1, Kent A Griffith, J Sybil Biermann, Felix Y Feng, David R Lucas, Edgar Ben-Josef.   

Abstract

PURPOSE: To identify high-risk patients with desmoid tumors who could benefit from postoperative radiotherapy (RT) and to determine the efficacy of postoperative and definitive RT.
MATERIALS AND METHODS: Retrospective analysis of clinical data for all patients with desmoid tumors who underwent definitive local therapy at the University of Michigan from 1984 through 2008. Estimates for local control were calculated using the product-limit method of Kaplan and Meier, and associations with patient, tumor, and RT characteristics were explored using Cox proportional hazard regression.
RESULTS: Treatment for 95 patients who qualified for the study included surgery, RT, or both in 54, 13, and 28 cases, respectively. With a median follow-up of 38 months, the actuarial 3-year local control (95% confidence interval [CI]) was not significantly different (p = 0.3) among the three treatment groups: 84.6% (70.2-92.4), 92.3% (56.6-98.9), and 69.0% (43.1-84.9), respectively. Tumor site in the head/neck (p = 0.03) and history of previous surgical therapy (p = 0.01) were associated with increased recurrence risk (HR = 2.8, 95% CI 1.1-7.4, and HR = 3.2, 95% CI = 1.3-7.8), whereas gender, age, use of RT, and positive margins were not (p > 0.2).
CONCLUSIONS: Our findings suggest equivalent local control rates after surgery, RT, or a combination of both. Although history of previous surgical therapy or site of origin in the head/neck region were found to be associated with increased risk of recurrence after local therapy, there was no clear association between surgical margin status and local control.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20615622     DOI: 10.1016/j.ijrobp.2010.02.053

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Intra-thoracic desmoid tumor.

Authors:  Deepak Aggarwal; Usha Dalal; Prasanta Raghab Mohapatra; Niti Singhal
Journal:  Lung India       Date:  2012-04

2.  Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.

Authors:  Chuanxi Zheng; Jianguo Fang; Yitian Wang; Yong Zhou; Chongqi Tu; Li Min
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-15       Impact factor: 4.553

3.  Radiotherapy in desmoid tumors : Treatment response, local control, and analysis of local failures.

Authors:  Kirsi Santti; Annette Beule; Laura Tuomikoski; Mikko Rönty; Anna-Stina Jääskeläinen; Kauko Saarilahti; Hanna Ihalainen; Maija Tarkkanen; Carl Blomqvist
Journal:  Strahlenther Onkol       Date:  2017-01-02       Impact factor: 3.621

4.  Postoperative radiotherapy in primary resectable desmoid tumors of the neck: a case-control study.

Authors:  Xiaoshuang Niu; Rui Jiang; Chaosu Hu
Journal:  Strahlenther Onkol       Date:  2019-06-06       Impact factor: 3.621

5.  Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature.

Authors:  Christopher J Schmoyer; Harmar D Brereton; Eric W Blomain
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

6.  Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Authors:  Nicholas A Mignemi; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Hernan Correa; Cheryl M Coffin; Jennifer O Black; Yajun Yi; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Jonathan G Schoenecker; Justin M M Cates
Journal:  Cancer Sci       Date:  2012-11-15       Impact factor: 6.716

7.  Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Jian-Wei Liang; Hui-Rong Hou; Zheng Wang; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  Tumour Biol       Date:  2014-05-02

8.  Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.

Authors:  Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2015-04-29       Impact factor: 3.201

Review 9.  A systematic review of active treatment options in patients with desmoid tumours.

Authors:  X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier; M Ghert
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

10.  Treatment and follow-up strategies in desmoid tumours: a practice guideline.

Authors:  M Ghert; X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.